Terms: = Lung cancer AND TNFRSF17, BCMA, 608, ENSG00000048462, CD269, Q02223, BCM AND Clinical Outcome
4 results:
1. Evaluate the Prognosis of
Cao J; J Gu J; Liang Y; Wang B
Technol Cancer Res Treat; 2022; 21():15330338221138213. PubMed ID: 36524293
[No Abstract] [Full Text] [Related]
2. Prognostic value of chemotherapy-resistant CK19mRNA-positive circulating tumor cells in patients with advanced/metastatic non-small cell lung cancer.
Milaki G; Messaritakis I; Koinis F; Kotsakis A; Apostolaki S; Dermitzaki EK; Perraki M; Hatzidaki D; Georgoulias V
Cancer Chemother Pharmacol; 2017 Jul; 80(1):101-108. PubMed ID: 28523597
[TBL] [Abstract] [Full Text] [Related]
3. Indeterminate but Likely Unimportant Extracolonic Findings at Screening CT Colonography (C-RADS Category E3): Incidence and outcomes Data From a clinical Screening Program.
Pooler BD; Kim DH; Pickhardt PJ
AJR Am J Roentgenol; 2016 Nov; 207(5):996-1001. PubMed ID: 27505184
[TBL] [Abstract] [Full Text] [Related]
4. XRCC1 Arg399Gln and clinical outcome of platinum-based treatment for advanced non-small cell lung cancer: a meta-analysis in 17 studies.
Chen J; Zhao QW; Shi GM; Wang LR
J Zhejiang Univ Sci B; 2012 Nov; 13(11):875-83. PubMed ID: 23125080
[TBL] [Abstract] [Full Text] [Related]
